Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Wave Life Sci Ord Sh (NQ: WVE ) 14.20 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 14.20 Bid (Size) 13.06 (5) Ask (Size) 16.62 (2) Prev. Close 14.20 Today's Range 14.20 - 14.20 52wk Range 3.500 - 15.92 Shares Outstanding 98,983,261 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024 November 04, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs October 30, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Performance YTD +165.92% +165.92% 1 Month +76.62% +76.62% 3 Month +137.46% +137.46% 6 Month +142.74% +142.74% 1 Year +146.96% +146.96% More News Read More 1 Brand-New Big Reason to Buy This Biotech Stock Right Now October 24, 2024 Via The Motley Fool Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space. October 21, 2024 Via Investor's Business Daily Oklo, CleanSpark And Wolfspeed Are Among Top 7 Mid Cap Gainers Last Week (Oct 14-18): Are The Others In Your Portfolio? October 20, 2024 Via Benzinga Wave Life Sciences Rockets 70% on Historic RNA Editing Success October 18, 2024 Via MarketBeat This Cisco Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday October 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session October 16, 2024 Via Benzinga Wave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In Humans October 16, 2024 Via Benzinga Wave Life Sciences Just Edited RNA — And Shares Hit The Stratosphere October 16, 2024 Via Investor's Business Daily United Airlines Posts Upbeat Earnings, Joins Morgan Stanley, U.S. Bancorp And Other Big Stocks Moving Higher On Wednesday October 16, 2024 Via Benzinga Wave Life Sciences Announces First-Ever Therapeutic RNA Editing in Humans Achieved in RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency October 16, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Announces Upcoming Virtual Research Day on Wednesday, October 30, 2024 October 16, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Better Biotech Stock: Wave Life Sciences vs. Sarepta Therapeutics October 03, 2024 Via The Motley Fool Wave Life Sciences Announces Closing of Upsized Public Offering of Ordinary Shares and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares October 01, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences to Present at Chardan 8th Annual Genetic Medicines Conference September 30, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Wave Life Sciences Prices Upsized $200 Million Public Offering of Ordinary Shares and Pre-Funded Warrants September 25, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire General Motors To $42? Here Are 10 Top Analyst Forecasts For Wednesday September 25, 2024 Via Benzinga Stitch Fix Reports Weak Earnings, Joins KB Home And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session September 25, 2024 Via Benzinga Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants September 24, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Crude Oil Gains Over 1%; BioVie Shares Plunge September 24, 2024 Via Benzinga Exposures Fossil Fuels Nasdaq Surges 100 Points; Thor Industries Earnings Top Views September 24, 2024 Via Benzinga Wave Life Sciences Stock Surges On Promising Interim Data From Mid-Stage Study Of Muscular Disorder Drug September 24, 2024 Via Benzinga Wave Life Sciences, Nio, Li Auto, Tesla And Other Big Stocks Moving Higher On Tuesday September 24, 2024 Via Benzinga Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping September 24, 2024 From Wave Life Sciences USA, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
